Eugene K Cha

8PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

|May 01, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.

Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran

|Jan 05, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

Jonathan A Coleman, Wesley Yip, Nathan C Wong

|Jun 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.

Nima Almassi, Karissa Whiting, Antoun Toubaji

|Jan 28, 2022
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.

Samuel A Funt, Michael Lattanzi, Karissa Whiting

|Apr 18, 2021
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.

Nima Almassi, Emily A Vertosick, Daniel D Sjoberg

Pageof 2